Literature DB >> 9219705

Insulin lispro.

F Holleman1, J B Hoekstra.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9219705     DOI: 10.1056/NEJM199707173370307

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  34 in total

Review 1.  Modern pharmacotherapies for type 2 diabetes mellitus.

Authors:  S H Hsia
Journal:  J Natl Med Assoc       Date:  2001-09       Impact factor: 1.798

2.  New protein footprinting: fast photochemical iodination combined with top-down and bottom-up mass spectrometry.

Authors:  Jiawei Chen; Weidong Cui; Daryl Giblin; Michael L Gross
Journal:  J Am Soc Mass Spectrom       Date:  2012-06-06       Impact factor: 3.109

Review 3.  Insulin analogues and management of diabetes mellitus.

Authors:  B Vaidyanathan; P S Menon
Journal:  Indian J Pediatr       Date:  2000-06       Impact factor: 1.967

4.  Intrinsic fibrillation of fast-acting insulin analogs.

Authors:  R Jeremy Woods; Javier Alarcón; Elaine McVey; Ronald J Pettis
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

Review 5.  Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence.

Authors:  Israel Hartman
Journal:  Clin Med Res       Date:  2008-09-18

6.  Engineering Synthetically Modified Insulin for Glucose-Responsive Diabetes Therapy.

Authors:  Matthew J Webber; Daniel G Anderson; Robert Langer
Journal:  Expert Rev Endocrinol Metab       Date:  2015-07-18

Review 7.  Insulin lispro (Humalog), the first marketed insulin analogue: indications, contraindications and need for further study.

Authors:  A L Puttagunta; E L Toth
Journal:  CMAJ       Date:  1998-02-24       Impact factor: 8.262

8.  Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects.

Authors:  J Shafqat; E Melles; K Sigmundsson; B-L Johansson; K Ekberg; G Alvelius; M Henriksson; J Johansson; J Wahren; H Jörnvall
Journal:  Cell Mol Life Sci       Date:  2006-08       Impact factor: 9.261

9.  Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial.

Authors:  Susan J Logtenberg; Nanne Kleefstra; Sebastiaan T Houweling; Klaas H Groenier; Reinold O Gans; Evert van Ballegooie; Henk J Bilo
Journal:  Diabetes Care       Date:  2009-05-08       Impact factor: 17.152

10.  Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes.

Authors:  Yoeri M Luijf; Arianne C van Bon; Joost B Hoekstra; J Hans Devries
Journal:  Diabetes Care       Date:  2010-08-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.